- All
- 2026-06-11 [Thursday]
- 2026-06-12 [Friday]
- 2026-06-13 [Saturday]
- 2026-06-14 [Sunday]
- All
- A1-A (102-107)
- A1-A101
- A1-A102
- A1-A103
- A1-A104
- A1-A (105-107)
- A1-A108
- A1-A109
- A1-A110
- A2-A206
- A2-A207
- A2-A208
- A2-A213
- A2-A214
- A2-A215
- B1 Hall (Poster Area)
- B1 Hall (Exhibition Area)
2026-06-14 (Sunday)
A1-A108
| NO. | Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 10:00-10:06 |
Immune microenvironment remodeling in patients with unresectable hepatocellular carcinoma pre- versus post- transarterial chemoembolization combined with tyrosine kinase inhibitors and immune checkpoint inhibitors: insights from single-cell transcriptomic profiling |
Hai-Feng Zhou | Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University), China |
| 2 | 10:08-10:14 |
Clinical efficacy of HAIC (RALOX) combined with systemic therapy vs. TACE combined with systemic therapy in the treatment of advanced hepatocellular carcinoma with arterioportal fistulas |
Ru-Jian Wang | The Affiliated Yantai Yuhuangding Hospital of Qingdao University, China |
| 3 | 10:16-10:22 |
Two Cases of Hepatocellular Carcinoma Rupture Following Transarterial Chemoembolization with Radiopaque Small-caliber Drug-eluting Microspheres |
Xinran Guo | Chengdu Medical College, China |
| 4 | 10:24-10:30 |
Efficacy, Survival, and Cost-effectiveness Associated With cTACE vs DEB-TACE for Treatment of Solitary Large HCC: A Propensity-Matched Study |
Mu Ding | Binzhou Medical University Hospital, China |
| 5 | 10:32-10:38 |
Prediction of overall survival in unresectable HCC receiving TACE plus atezolizumab and bevacizumab: A multicenter retrospective study |
Li-Wei Deng | The Cancer Institute and Hospital, Chinese Academy of Medical Sciences (CAMS), China |
| 6 | 10:40-10:46 |
Multiscale Intra- and Peritumoral MRI Radiomics Combined with Pathological Spatial Heterogeneity for Recurrence Prediction in Hepatocellular Carcinoma After Resection and Adjuvant TACE |
Chun-Li Kong | The Fifth Affiliated Hospital of Wenzhou Medical University, China |
| 7 | 10:46-10:52 |
TBD |
Yan Chen | med |
